Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies

• Auteurs principaux: Marr J (Auteur), Huang Z (Auteur), Wang B (Auteur), Zhang H (Auteur), Roth K (Auteur)
• Format: Livre
• Publié: Dove Medical Press, 2015-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Joachim Marr,1 Zirong Huang,2 Baoxi Wang,3 Hongyan Zhang,4 Katrin Roth1 1Bayer Pharma AG, Berlin, Germany; 2Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 3Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, 4Peking University Sixth Hospital,...